Rush University Cancer Center
Neuroendocrine Tumor Services
Chicago, Illinois
Contact information:
- See website
- Phone: (312) CANCER-1
Join NETRF’s ‘Research Changes Lives’ Giving Tuesday Campaign—Every gift doubled now through December 3, 2024. LEARN MORE
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $37.6 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
Home » Find a NET Specialist » Rush University Cancer Center
Chicago, Illinois
Rush offers a multidisciplinary team of doctors who are experts in the care of neuroendocrine tumors.
Rush was the first hospital in Illinois to use a detailed diagnostic test for neuroendocrine tumors, the 68-Ga DOTATATE PET CT. It was also the first hospital in the state to offer peptide receptor radionuclide therapy (PRRT), a recently approved treatment for GI and pancreatic neuroendocrine tumors.
Rush offers neuroendocrine tumor care at locations throughout Chicago, Oak Park, and Lisle. Contact Rush online or call (312) CANCER-1.